← back to search

Feng Liu

Peking University · CN
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Hepatitis C virus research, and Influenza Virus Research Studies.
h-index
37
citations
4,923
works
302
NIH funding
primary concept
Medicine
email

Recent publications

Use of Artificial Intelligence-Assisted Histopathology for Evaluation of Sex-Specific Progression and Regression of Hepatocellular Carcinoma Related to Metabolic Dysfunction-Associated Fatty Liver Disease.
2026cited by 0position: contributordoi
Intratumoral microbiota in orchestrating cancer immunotherapy response
Journal of Translational Internal Medicine 2024cited by 46position: middledoi
Association of AST/ALT ratio with 90-day outcomes in patients with acute exacerbation of chronic liver disease: a prospective multicenter cohort study in China
Frontiers in Medicine 2024cited by 20position: middledoi
Hepatic Steatosis Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Artificial Intelligence.
2024cited by 5position: contributordoi
Direct chemical induction of hepatocyte-like cells with capacity for liver repopulation.
2023cited by 22position: contributordoi
Artificial Intelligence Improves Pathologist Agreement for Fibrosis Scores in Nonalcoholic Steatohepatitis Patients.
2023cited by 15position: contributordoi
Burden of liver complications related to non-alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019.
2023cited by 15position: contributordoi
Development, External Validation, and Visualization of Machine Learning Models for Predicting Occurrence of Acute Kidney Injury after Cardiac Surgery
Reviews in Cardiovascular Medicine 2023cited by 10position: middledoi
LAMP3 expression in the liver is involved in T cell activation and adaptive immune regulation in hepatitis B virus infection.
2023cited by 8position: contributordoi
Characteristic gene expression in the liver monocyte-macrophage-DC system is associated with the progression of fibrosis in NASH.
2023cited by 7position: contributordoi
Quantitative image-based collagen structural features predict the reversibility of hepatitis C virus-induced liver fibrosis post antiviral therapies.
2023cited by 5position: contributordoi
Collagen co-localised with macrovesicular steatosis for fibrosis progression in non-alcoholic fatty liver disease
2023cited by 0position: contributordoi
Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis.
2022cited by 25position: contributordoi
Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients.
2022cited by 15position: contributordoi
Water Specific MRI T1 Mapping for Evaluating Liver Inflammation Activity Grades in Rats With Methionine-Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease.
2022cited by 7position: contributordoi
Mid-upper arm circumference is associated with liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease: A population based observational study.
2022cited by 6position: contributordoi
Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis.
2022cited by 4position: contributordoi
Appendicular Skeletal Muscle Index and HbA1c Evaluate Liver Steatosis in Patients With Metabolic Associated Fatty Liver Disease.
2022cited by 3position: contributordoi
Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.
2021cited by 33position: contributordoi
Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China.
2021cited by 2position: contributordoi
Studies on the level of neutralizing antibodies produced by inactivated COVID-19 vaccines in the real world
2021cited by 1position: contributordoi
Viral and host factors related to the clinical outcome of COVID-19
Nature 2020cited by 1,002position: middledoi
qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.
2020cited by 94position: contributordoi
STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease.
2020cited by 91position: contributordoi
An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials.
2020cited by 16position: contributordoi
The Effects of <i>Daxx</i> Knockout on Pluripotency and Differentiation of Mouse Induced Pluripotent Stem Cells
Cellular Reprogramming 2020cited by 4position: middledoi
qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis
Hepatology 2019cited by 119position: firstdoi
STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease
Laboratory Investigation 2019cited by 108position: middledoi
Second Harmonic Generation Reveals Subtle Fibrosis Differences in Adult and Pediatric Nonalcoholic Fatty Liver Disease
American Journal of Clinical Pathology 2017cited by 30position: firstdoi
Changes and clinical significance of peripheral white blood cells in patients with acute and chronic human brucellosis
Chin J Endemiol 2017cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Aileen Wee · National University of Singapore3 papers (2017–2019) · 3 papers (2023–2026)Jingmin Zhao · Jilin University3 papers (2017–2019)Lai Wei · The First Affiliated Hospital, Sun Yat-sen University3 papers (2017–2019) · 3 papers (2017–2019)Quentin M. Anstee · Newcastle upon Tyne Hospital2 papers (2019–2020)Qin Zhang · Hebei Medical University1 papers (2020–2020)Qin Wang · The First Affiliated Hospital, Sun Yat-sen University1 papers (2019–2019)Hai Li · Wenzhou Medical University1 papers (2024–2024)Xiaonan Zhang · Hebei Agricultural University1 papers (2020–2020)Wei Zhang · Hebei Medical University1 papers (2017–2017)Bing Chen · Shanghai Jiao Tong University1 papers (2020–2020)Xiaogang Wang · Sinopec (China)1 papers (2023–2023)Jun Chen · Guangzhou University of Chinese Medicine1 papers (2020–2020) · 1 papers (2023–2023)Lu Jiang · Hunan Entry-Exit Inspection and Quarantine Bureau1 papers (2020–2020)Yun-Tian Sun · Chinese PLA General Hospital1 papers (2023–2023)Meng Gao · Shandong Provincial Hospital1 papers (2020–2020) · 1 papers (2024–2024)Jinjun Chen · Ningbo University1 papers (2024–2024)